Astrana Health (NASDAQ:ASTH) Trading Down 6.3% – What’s Next?

by · The Cerbat Gem

Shares of Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) fell 6.3% during trading on Tuesday . The stock traded as low as $27.42 and last traded at $27.3750. 100,146 shares changed hands during mid-day trading, a decline of 78% from the average session volume of 457,647 shares. The stock had previously closed at $29.21.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on ASTH shares. Zacks Research lowered shares of Astrana Health from a “hold” rating to a “strong sell” rating in a research report on Monday, November 10th. Needham & Company LLC began coverage on Astrana Health in a report on Friday, December 12th. They issued a “buy” rating and a $28.00 target price on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. BTIG Research reduced their price target on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Finally, TD Cowen lowered their price objective on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a research report on Monday, November 10th. Eight analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $41.33.

Get Our Latest Research Report on ASTH

Astrana Health Trading Down 6.9%

The firm has a 50-day moving average of $24.36 and a 200 day moving average of $26.82. The company has a market cap of $1.53 billion, a P/E ratio of 143.17, a price-to-earnings-growth ratio of 0.71 and a beta of 0.87. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27.

Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46). The business had revenue of $956.05 million during the quarter, compared to the consensus estimate of $952.83 million. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The company’s revenue for the quarter was up 99.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 earnings per share. On average, analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASTH. Royal Bank of Canada increased its holdings in shares of Astrana Health by 6.5% during the first quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after acquiring an additional 17,028 shares in the last quarter. AQR Capital Management LLC acquired a new stake in Astrana Health in the 1st quarter valued at $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Astrana Health by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock valued at $799,000 after purchasing an additional 1,263 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in Astrana Health by 4,365.2% during the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock worth $346,000 after buying an additional 10,913 shares during the last quarter. Finally, Intech Investment Management LLC lifted its stake in shares of Astrana Health by 5.8% in the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock valued at $1,383,000 after buying an additional 2,462 shares in the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

Read More